Skip to main navigation

Search

Close

Search

Close

Investors and Media

Events and Presentations

Upcoming Events

Cantor Global Healthcare Conference

September 19, 2024 at 9:10 AM EDT

Listen to webcast

Add to Google Calendar

Archived Events

Wells Fargo Healthcare Conference

September 5, 2024 at 12:45 PM EDT

Listen to webcast

Truist Tru-Talks Series Webcast

August 8, 2024

Goldman Sachs 45th Annual Global Healthcare Conference

June 10, 2024 at 10:40 AM EDT

Listen to webcast

Jefferies Global Healthcare Conference

June 6, 2024 at 11:00 AM EDT

Listen to webcast

UBS Spring Biotech Conferences

May 21, 2024

BofA Securities 2024 Healthcare Conference

May 14, 2024 at 3:30 PM PDT

Listen to webcast

UBS Virtual CNS Day 2024

March 18, 2024

Listen to webcast

Jefferies Biotech on the Bay Summit

March 13, 2024

Leerink Partners Global Biopharma Conference

March 12, 2024 at 1:00 PM EDT

Listen to webcast

Stifel Webinar: ARV-102: Arvinas’ Oral LRRK2 PROTAC Degrader

February 14, 2024

Listen to webcast

6th Annual Guggenheim Biotechnology Conference

February 7, 2024 at 10:30 AM EST

Listen to webcast

Arvinas SABCS Data Presentation

December 6, 2023 at 7:30 AM EST

Listen to webcast

6th Annual Evercore ISI HealthCONx Conference

November 30, 2023 at 9:10 AM EST

Listen to webcast

Piper Sandler 35th Annual Healthcare Conference

November 28, 2023 at 9:00 AM EST

Listen to webcast

Jefferies London Healthcare Conference

November 16, 2023

Stifel Healthcare Conference

November 14, 2023 at 10:20 AM EST

Listen to webcast

Truist Securities BioPharma Symposium

November 8, 2023

ESMO Data Presentation

October 22, 2023 at 9:00 AM EDT

Listen to webcast

Cantor Global Healthcare Conference

September 28, 2023 at 11:30 AM EDT

Listen to webcast

Presentations

Arvinas Corporate Presentation – July 2024

July 30, 2024

Stifel Webinar: ARV-102: Arvinas’ Oral LRRK2 PROTAC Degrader

February 20, 2024

ARV-766: Phase 1 and Interim Phase 2 Data – June 2023

June 8, 2023

41st Annual J.P. Morgan Healthcare Conference Presentation

January 17, 2023

ARV-471: Phase 2 VERITAC Trial Results

December 8, 2022

Bavdegalutamide (ARV-110): Phase 1 Dose Escalation and Interim ARDENT Phase 2 Dose Expansion Trial Results

February 17, 2022

ARV-471: Phase 1 Dose Escalation Clinical Trial Results

December 10, 2021

2021 Targeted Protein Degradation Summit

October 27, 2021

ARV-471 Collaboration Presentation

July 22, 2021

Clinical Program Update: ARV-471 & ARV-110

December 14, 2020

Current page 1
Page 2
Next page
Last page

Print Page

Print Page
RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Search

Search

Careers
Privacy Policy
Terms of Use

Menu

Careers
Privacy Policy
Terms of Use

Linkedin-in Twitter

© 2024 Arvinas. All rights reserved.

Search

Close

Our Science

About Us

Pipeline and Research

Careers and Culture

Patients

Investors and Media

Contact Us

Menu

Contact Us

Linkedin-in Twitter